Julian Lin updates his views on cannabis REITs IIPR and NewLake Capital and shares his changed thesis on MSOs.

CNBS's portfolio is less concentrated in a few stocks compared to MSOS, reducing risk. Check out why I rate the fund a buy.

Robert F. Kennedy Jr., seen as pro-cannabis, is heading toward expected approval as Health and Human Services secretary, ...

In its time as a public company, the stock has more than tripled. Its dividend yields more than 11% at the current share price. Let's get the headline math question out of the way first. A $5,000 ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

America’s largest legal cannabis companies are backing the formation of the U.S. Cannabis Roundtable, a new advocacy group taking aim at the logjam around marijuana reform on the federal level ...

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical marijuana company in the U.S., today announced the relocation of a ...

TALLAHASSEE, Fla., Jan. 24, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical marijuana company in the U.S., ...